News 05/26/1992
P92-15 Food and Drug Administration
FOR IMMEDIATE RELEASE Brad Stone - (202) 245-1144
HHS Secretary Louis W. Sullivan, M.D., today announced a policy that
will improve the variety of the U.S. food supply by promoting the
development through biotechnology of new foods that are safe for consumers.
The policy statement lays out a structure under which the Food and Drug
Administration will regulate new varieties of whole foods developed through
biotechnology by applying the same standards as for all other foods.
Foods developed by biotechnology are not currently on the market, but
companies are conducting extensive research in this area, and some of their
products will soon be ready for commercialization. Manufacturers have
sought such a statement of how products would be regulated so that they know
how to proceed. FDA's development of this policy was expedited under the
direction of the Biotechnology Working Group of the President's Council on
Competitiveness.
"These new technologies will benefit all Americans by providing foods
that are tastier, more varied, more wholesome and that can be produced more
efficiently," Dr. Sullivan said. "The policy we are announcing today will
ensure the safety of these foods while facilitating their availability as
quickly as possible.
-MORE-
Page 2, P92-15, Food Biotech Policy
"Fruits, vegetables and grains developed through biotechnology mark an
evolutionary step in the production of new varieties. They will give
producers new tools through which to introduce improved traits in crops to
benefit growers, processors and consumers."
"The American biotechnology industry leads the world in the development
and application of recombinant DNA techniques," said FDA Commissioner David
A. Kessler, M.D. "We will soon see the same kinds of remarkable
contributions to the food supply that the new biotechnology has brought to
pharmaceuticals during the past decade. This FDA policy is an example of
this administration's commitment to both protect the public health and
foster technological innovation," Dr. Kessler said.
The policy, to be published soon in the Federal Register, describes the
scientific basis for evaluating and ensuring the safety of new varieties of
foods produced with any technique, including those of the new biotechnology,
such as recombinant DNA or "gene splicing." The scientific concepts
described in the policy are consistent with those embodied in a food safety
document about to be released by the Group of National Experts on Safety in
Biotechnology of the Organization for Economic Cooperation and Development
(OECD). It also discusses the legal requirements for products that are to
be marketed.
The new biotechnology holds considerable promise for the development of
new varieties of foods that are more palatable, more nutritious, or that
possess other desirable traits. The potential exists for many new or
enhanced traits to be introduced -- for example, fruits and vegetables that
are more resistant to cold or droughts, or that contain higher-quality
protein.
-MORE-
Page 3, P92-15, Food Biotech Policy
The Food, Drug, and Cosmetic Act requires producers to ensure that the
foods they market are safe and allows FDA to take enforcement action against
foods that may be injurious to health. The act gives FDA authority to
conduct pre-market review of new substances in food that raise concerns
about safety or that under the act are food additives.
FDA is one of the eight Public Health Service agencies within HHS.
###